Dr. New is a founder and CEO of Radyus Research. She is an experienced drug developer with a background in early-stage venture capital, considerable pharma R&D, and university technology transfer.
Dr. New received her PhD in immunology and microbiology from the University of Illinois at Chicago and a postdoctoral fellowship at Northwestern University. She also earned an MBA in finance and marketing at Kellogg School of Management.
Dr. New spent most of her career translating early academic research into differentiated therapeutics and draws her expertise from Baxter, Baxalta, and Agent Capital positions. She participated in building several successful academic spinouts and invested in over 20 biotech companies. Dr. New is passionate about advising Radyus clients on product development, fundraising, and commercialization strategies.
Dr. New received her PhD in immunology and microbiology from the University of Illinois at Chicago and a postdoctoral fellowship at Northwestern University. She also earned an MBA in finance and marketing at Kellogg School of Management.
Dr. New spent most of her career translating early academic research into differentiated therapeutics and draws her expertise from Baxter, Baxalta, and Agent Capital positions. She participated in building several successful academic spinouts and invested in over 20 biotech companies. Dr. New is passionate about advising Radyus clients on product development, fundraising, and commercialization strategies.
Speaking In
11:00 AM - 12:00 PM
Wednesday, June 7
